Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessElon Musk tweets that there are “negative reactions” to second shot of...

Elon Musk tweets that there are “negative reactions” to second shot of COVID-19

Add to Favorite
Added to Favorite

 

On Friday, Elon Musk tweeted inaccurately about the second dose of the coronavirus vaccine saying that there has been “some debate” about it being more harmful than the first. However, experts on the matter have said that both doses are safe and the side effects, which occur in a small percentage of people, will subside in a few days.

 

According to research conducted by the Centers for Disease Control and Prevention, although allergic reactions occur, they are rare. A very small percentage of people get allergic reactions; about 4.5 reactions per one million doses which is 0.00045%.

 

Studies on the Pfizer vaccine have shown that it is safe to use. Research data by FDA mentions that some participants had side effects such as headache, fever and fatigue after the second dose but the numbers are low.

 

The FDA research showed that 31% of people who were in 18-55 age group reported that they got fever after getting the second jab of the Pfizer vaccine and 17% of them got it after the second jab of the Moderna vaccine.

 

All vaccines, not only the COVID-19 vaccines, can have mild side effects on certain individuals but the side effects generally go away within a day or few days.

 

The timing of Musk’s tweet has been pondered upon as The Washington Post reported on Friday, the same day as the tweet that of the roughly 10,000 workers tested for COVID-19 at the Tesla factory in California more than 400 tested positive for the coronavirus between May and December. Despite local state orders, Musk had kept the factory open.

 

In March 2020 he had tweeted that the “coronavirus panic is dumb.” He grandiosely stated that there would be “close to zero new cases in April.” He also proposed that mass infections should be allowed before vaccines were made available.

 

Incidentally Elon Musk himself caught COVID-19 and had to miss the legendary first NASA full crew launch on SpaceX to the ISS in November 2020. He has even been called a Space Karen recently.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Advance Auto Parts Downgraded to Sell Amid Earnings Miss and Weak Outlook

CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold...

Guggenheim Reiterates Buy Rating on Cabaletta Bio Amid Promising Data

Guggenheim analysts reaffirmed a Buy rating and a $23...

Goldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Goldman Sachs analysts initiated coverage on Doximity (NYSE:DOCS) with...